- PGNX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $13.7 million.
- PGNX has traded 482,397 shares today.
- PGNX is down 3.2% today.
- PGNX was up 7.6% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PGNX with the Ticky from Trade-Ideas. See the FREE profile for PGNX NOW at Trade-Ideas More details on PGNX: Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. PGNX has a PE ratio of 121. Currently there is 1 analyst that rates Progenics Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold. The average volume for Progenics Pharmaceuticals has been 950,200 shares per day over the past 30 days. Progenics has a market cap of $506.3 million and is part of the health care sector and drugs industry. The stock has a beta of 2.75 and a short float of 25.9% with 6.62 days to cover. Shares are up 3.4% year-to-date as of the close of trading on Monday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.